New Frontiers in Contraceptive Research A Blueprint for Action (2004) / Chapter Skim
Currently Skimming:
Appendix B: Agendas and Participants in Committee Workshops
Appendix B: Agendas and Participants in Committee Workshops
Pages 202-211
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 202... ...
APPENDIX B Agenclas and Parlicipants in Committee Workshops International Symposium on New Frontiers in Contraceptive Research The National Academies 2101 Constitution Avenue Washington, DC TUESDAY, JULY 15, 2003 8:00 AM WELCOME REMARKS Jerome Strauss, M.D., Ph.D., University of Pennsylvania INTRODUCTION TO SYMPOSIUM Allan Rosenfield, M.D., Columbia University 8:30 AM DISCOVERY APPROACH TO TARGET SELECTION AND VALIDATION Moderator: Robert Braun, Ph.D., University of Washington Moderator: Martin Matzuk, M.D., Ph.D., Baylor College of Medicine Insights from the testicular transcriptome: Michael Griswold, Ph.D., Washington State University Proteomics and the discovery of contraceptive drug and vaccine targets: John C Herr, Ph.D., University of Virginia Toward a comprehensive analysis of the genetic control of male fertility: Barbara Wakimoto, Ph.D., University of Washington 202
|
From page 203... ...
Kopf, Ph.D., Wyeth Research Charles Grudzinskas, Ph.D., Drug Development Consultant 12:15 PM LUNCH 1:15 PM FUNCTIONAL TARGETS FOR CONTRACEPTION Moderator: Linda Giudice, M.D., Ph.D., Stanford University Moderator: Gregory S Kopf, Ph.D., Wyeth Research Leptin peptide antagonists: Down-regulation of leptin actions in embryo implantation: Ruben Gonzalez, Ph.D., Boston Biomedical Research Institute Gamete membrane fusion: A genetic approach: Diana Myles, Ph.D., University of California, Davis Using chemical genetics to study regulators of fertility: Caroline Shamu, Ph.D., Harvard Medical School 2:45 PM BREAK 3:00 PM SMALL GROUP DISCUSSIONS STD Prevention and Contraception: Should research be pursued jointly or separately?
|
From page 204... ...
Moderator: Michael Harper, Ph.D., Sc.D., CONRAD Evaluation of Contraceptives: What are the obstacles to preclinical evaluation and proof of concept in contraceptive development and how can they be overcome? Moderators: Marlene Cohen, Ph.D., Independent Consultant; Ruth Merkatz, Ph.D., R.N., Pfizer 5:00 PM ADJOURN WEDNESDAY, JULY 16, 2003 8:00 AM ADVANCES IN MATERIALS SCIENCE Moderator: Lisa Brannon-Peppas, Ph.D., University of Texas, Austin Overview of controlled release: Thomas Tice, Ph.D., Southern Research Institute An overview of controlled release technology in contraceptive devices: Camilla Santos, Ph.D., Spherics, Inc.
|
From page 205... ...
Dickson, M.D., Reproductive Health Research Unit, South Africa 2:45 PM BREAK 3:00 PM PANEL DISCUSSION Moderator: Nancy Padian, Ph.D., University of California, San Francisco Diana Blithe, Ph.D., National Institute of Child Health and Human Development, National Institutes of Health Laneta Dorflinger, Ph.D., Family Health International Henry Gabelnick, Ph.D., CONRAD Maurizio Macaluso, M.D., Dr.PH, Centers for Disease Control and Prevention Jeffrey Spieler, U.S. Agency for International Development 4:30 PM SUMMARY Jerome Strauss, M.D., Ph.D., University of Pennsylvania 5:00 PM ADJOURN
|
From page 206... ...
* Kurt Barnhart University of Pennsylvania Wendy Barr University of Pennsylvania Margaret Battin University of Utah Gabriel Bialy National Institute of Child Health and Human Development, National Institutes of Health Holly Blanchard Planned Parenthood of Metropolitan Washington, DC *
|
From page 207... ...
Grudzinskas Drug Development Consultant 207 ~Mahmoud Fathalla Assiut University, Egypt Mary Feeney National Academy of Sciences Shira Fischer Institute of Medicine Karin French Takoma Park, MD Linda C Giudice Stanford University Medical Center Anna Glasier Lothian Primary Care NHS Trust Phyllis Greenberger Society for Women's Health Research Gary Grubb Wyeth Research *
|
From page 208... ...
* Sponsor Representative NEW FRONTIERS IN CONTRACEPTIVE RESEARCH rune Lee National Institutes of Health Phyllis Leppert National Institute of Child Health and Human Development, National Institutes of Health Yi-Nan Lin Baylor College of Medicine Kim Lundberg George Washington University Joanne Luoto National Institutes of Health *
|
From page 209... ...
* Diana Myles University of California, Davis Sharyl Nass Institute of Medicine 209 Deborah O'Brien University of North Carolina School of Medicine Ann O'Hanlon National Partnership for Women & Families Nancy Padian University of California, San Francisco Gordon Perkin Bill and Melinda Gates Foundation Tracy Rankin National Institutes of Child Health and Human Development *
|
From page 210... ...
* Caroline Shamu Harvard Medical School Karen Shea Planned Parenthood Federation of America Emily Shen Wyeth Pharmaceuticals Wayne Shields Association of Reproductive Health Professionals Viviana Simon Society for Women's Health Research Ashley Simons-Rudolph The George Washington University Engine Sitruk-Ware Population Council Harris Solomon USAID Jeff Solomon Wyeth Pharmaceutical *
|
From page 211... ...
* Kevin Whaley Epicyte Merrick Wright Johns Hopkins School of Public Health Wei Yan Baylor College of Medicine Koji Yoshinaga NICHD, NIH
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.